CKM and intrahepatic cholangiocarcinoma: Then, using ICC organoid models and multiple mouse ICC tumor models, we demonstrated that si‐cPKM could not only kill ICC internally in combination with paclitaxel but also reduce ICC tumor stromal fibrosis and increase microvascular opening, thus opening the gate for drug treatment.